Published in Arch Neurol on December 01, 1996
Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature (2000) 2.81
Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry (2005) 2.54
CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet (2010) 2.31
Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull (2010) 1.79
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci (2010) 1.76
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord (2009) 1.73
Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain (2007) 1.54
Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia (2007) 1.54
Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry (2010) 1.53
Obsessive and compulsive symptoms in prediagnosed Huntington's disease. J Clin Psychiatry (2008) 1.17
Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease. J Neurol (2008) 1.15
Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience (2009) 1.14
Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry (2011) 1.09
Functional imaging in Huntington's disease. Exp Neurol (2009) 1.08
Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology (2010) 1.07
Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder. J Psychiatr Res (2012) 1.07
Caregiving by teens for family members with Huntington disease. J Fam Nurs (2009) 1.04
Early atrophy of pallidum and accumbens nucleus in Huntington's disease. J Neurol (2010) 1.04
Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology (2010) 1.00
Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99
Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage (2011) 0.98
Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice. Neurobiol Dis (2013) 0.95
The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease. Neuropsychologia (2013) 0.94
Neuroprotection for Huntington's disease: ready, set, slow. Neurotherapeutics (2008) 0.92
Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease. Hum Brain Mapp (2013) 0.89
Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation. Mov Disord (2011) 0.89
Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol (2001) 0.87
"Pre-symptomatic" Huntington's disease. Handb Clin Neurol (2008) 0.85
Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression? J Clin Neurol (2013) 0.84
Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II. J Clin Exp Neuropsychol (2008) 0.83
Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year. Mov Disord (2011) 0.83
Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum Brain Mapp (2015) 0.82
In vivo basal ganglia volumetry through application of NURBS models to MR images. Neuroradiology (2006) 0.82
Parallel explicit and implicit control of reaching. PLoS One (2009) 0.81
Age-at-onset in Huntington disease. PLoS Curr (2011) 0.78
Neuroimaging in Huntington's disease. World J Radiol (2014) 0.78
Striatal hypometabolism in premanifest and manifest Huntington's disease patients. Eur J Nucl Med Mol Imaging (2016) 0.77
Magnetization transfer imaging in 'premanifest' Huntington's disease. J Neurol (2009) 0.77
Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker. Neurology (2014) 0.76
Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease. Neuropsychology (2011) 0.76
Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington's disease. Mol Neurodegener (2012) 0.76
Sub-millimeter isotropic MRI for segmentation of subcortical brain regions and brain visualization. J Magn Reson Imaging (2010) 0.75
Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration. Hum Brain Mapp (2017) 0.75
Strengthened Corticosubcortical Functional Connectivity during Muscle Fatigue. Neural Plast (2016) 0.75
Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington's Disease. PLoS Curr (2015) 0.75
Progress in Huntington's disease: the search for markers of disease onset and progression. J Neurol (2015) 0.75
A method for making group inferences from functional MRI data using independent component analysis. Hum Brain Mapp (2001) 12.54
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet (2002) 6.12
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis (2010) 5.24
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis (2009) 4.37
Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet (1996) 4.20
The natural history of recovery for the healthcare provider "second victim" after adverse patient events. Qual Saf Health Care (2009) 3.79
Spatial and temporal independent component analysis of functional MRI data containing a pair of task-related waveforms. Hum Brain Mapp (2001) 3.78
Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage (2001) 3.58
Endonasal laser dacryocystorhinostomy. A new approach to nasolacrimal duct obstruction. Arch Ophthalmol (1990) 3.36
Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J (1988) 3.33
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol (2001) 3.09
fMRI activation in a visual-perception task: network of areas detected using the general linear model and independent components analysis. Neuroimage (2001) 2.94
Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology (2004) 2.81
Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature (2000) 2.81
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum (2003) 2.78
Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol (1999) 2.65
Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci (1996) 2.53
Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry (1990) 2.41
A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. Int J Parasitol (2004) 2.34
fMRI analysis with the general linear model: removal of latency-induced amplitude bias by incorporation of hemodynamic derivative terms. Neuroimage (2004) 2.28
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis (2004) 2.26
Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain (2003) 2.24
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum (2003) 2.20
Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. Am Heart J (1986) 2.05
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (1986) 2.00
Time-dependent motor memory processes in amnesic subjects. J Neurophysiol (1998) 1.99
Association between executive attention and physical functional performance in community-dwelling older women. J Gerontol B Psychol Sci Soc Sci (1999) 1.98
Method for multimodal analysis of independent source differences in schizophrenia: combining gray matter structural and auditory oddball functional data. Hum Brain Mapp (2006) 1.96
Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet (1994) 1.94
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology (1995) 1.92
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology (2008) 1.91
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis (2006) 1.86
Self-selection in predictive testing for Huntington's disease. Am J Med Genet (1994) 1.84
Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet (1995) 1.84
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology (Oxford) (2005) 1.82
Quality of life in patients with Alzheimer's disease as reported by patient proxies. J Am Geriatr Soc (1996) 1.78
Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry (1991) 1.78
A 14-year experience with 6 cm as a criterion for surgical treatment of abdominal aortic aneurysm. Br J Surg (1999) 1.76
Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology (2004) 1.74
Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74
Brain tumor imaging in clinical trials. AJNR Am J Neuroradiol (2008) 1.73
Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone. Biochim Biophys Acta (1975) 1.73
MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology (1999) 1.72
The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc (1999) 1.71
Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus (1993) 1.69
Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology (1993) 1.68
Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord (2000) 1.67
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology (2006) 1.65
Independent component analysis of fMRI data in the complex domain. Magn Reson Med (2002) 1.65
Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry (2000) 1.64
The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry (1997) 1.63
Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread--a hitherto unrecognised phenomenon in man. Eur Heart J (1997) 1.63
Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet (1984) 1.62
Cavernous hemangioma of the orbit. J Neurosurg (1979) 1.61
Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology (1994) 1.61
Motor signs predict poor outcomes in Alzheimer disease. Neurology (2005) 1.60
Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology (1994) 1.60
Infliximab treatment of severe ankylosing spondylitis: one-year followup. Arthritis Rheum (2001) 1.58
A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. J Clin Psychiatry (1991) 1.57
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis (2004) 1.56
Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain (1999) 1.56
Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology (1997) 1.56
Congenital dacryocele. A collaborative review. Ophthalmology (1991) 1.54
Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry (1997) 1.54
Effect of air ions on bacterial aerosols. Int J Biometeorol (1964) 1.53
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis (2004) 1.53
Neuronal chronometry of target detection: fusion of hemodynamic and event-related potential data. Neuroimage (2005) 1.51
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis (2005) 1.51
Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology (1995) 1.50
PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry (1997) 1.50
Pyrogenicity of poly I. poly C in rabbits. Nature (1969) 1.49
Sinus histiocytosis involving the lacrimal sac and duct. A clinicopathologic case report. Arch Ophthalmol (1991) 1.48
Conventional treatments for ankylosing spondylitis. Ann Rheum Dis (2002) 1.48
Motor signs during the course of Alzheimer disease. Neurology (2004) 1.47
Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry (1998) 1.46
Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry (2001) 1.46
Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry (1992) 1.46
Cloning and sequencing of the immunoglobulin A1 protease gene (iga) of Haemophilus influenzae serotype b. Infect Immun (1989) 1.45